Mice lacking mitochondrial superoxide dismutase (SOD2) show compromised mitochondria! function in association with neonatal lethality and cardiomyopathy, anemia, hyperlipidemia in the liver, enhanced cell death and genomic instability, and excess production of reactive oxygen species. Perhaps the most striking phenotypes that develop in these mice are centered in the brain. Sod2 null mice over two weeks of age rapidly develop a regionally specific spongiform encephalopathy, accompanied by gliosis in addition to a neurodegeneration not colocalized with the encephalopathy itself. We have characterized many of the phenotypes in sod2 null mice in conjunction with effective antioxidant interventions that prevent or attenuate the pathological consequences of mitochondrial oxidative stress. This proposal will test the hypothesis that increasing mitochondrial oxidative stress over time is associated with synaptic dysfunction and hyperphosphorylation of tau. We propose that interventions that reduce mitochondrial oxidative stress will also reduce synaptic dysfunction and tau pathology. We also propose that mitochondrial oxidative stress significantly impacts brain function in adult mice, and will test this via characterization of an temporal and tissue specific inducible knockout of sod2. We propose to test these hypotheses via the following specific aims: 1. Characterization of synaptosomal function with increasing age in sod2 nullizygous mice.
This specific aim will test the hypothesis that between 10and 20 days of age, synaptosomes from sod2 nullizygous mice have increased ROSthat directly impacts mitochondrial function. 2. Characterize the development of hyperphosphorylation of tau in sod2 nullizygous mice though quantitative Western blotting and gene expression profiling. We have made the novel observation that tau is hyperphosphorylated as a result of mitochondrial oxidative stress.
This specific aim will characterize the development of hyperphosphorylation in tau in sod2 null mice through proteomic studies on tau, in conjunction with gene expression profiling. 3. Characterization of a neuronal specific inducible knockout of sod2. Having characterized the consequences of mitochondrial oxidative stress in synaptosomes and tau, we will study the consequences of mitochondrial dysfunction in adult mouse brain. Specifically we will a) evaluate neuropathology of inducible sod2 null mice at various times throughout their lives to evaluate the effect of age on pathological outcomes from mitochondrial oxidative stress triggered at different times throughout life, and b) evaluate the phosphorylation status of tau, using age as an independent variable.
|Leonoudakis, Dmitri; Rane, Anand; Angeli, Suzanne et al. (2017) Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease. Mediators Inflamm 2017:8302636|
|Chinta, Shankar J; Woods, Georgia; Rane, Anand et al. (2015) Cellular senescence and the aging brain. Exp Gerontol 68:3-7|
|Siddiqui, Almas; Bhaumik, Dipa; Chinta, Shankar J et al. (2015) Mitochondrial Quality Control via the PGC1?-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin. J Neurosci 35:12833-44|
|Velarde, Michael C; Demaria, Marco; Melov, Simon et al. (2015) Pleiotropic age-dependent effects of mitochondrial dysfunction on epidermal stem cells. Proc Natl Acad Sci U S A 112:10407-12|
|Laberge, Remi-Martin; Sun, Yu; Orjalo, Arturo V et al. (2015) MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 17:1049-61|
|Lieu, Christopher A; Dewey, Colleen M; Chinta, Shankar J et al. (2014) Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model. Brain Res 1591:111-7|
|Blaschko, Sarah D; Chi, Thomas; Miller, Joe et al. (2013) Strontium substitution for calcium in lithogenesis. J Urol 189:735-9|
|Flynn, James M; O'Leary, Monique N; Zambataro, Christopher A et al. (2013) Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 12:851-62|
|Brand, M D; Orr, A L; Perevoshchikova, I V et al. (2013) The role of mitochondrial function and cellular bioenergetics in ageing and disease. Br J Dermatol 169 Suppl 2:1-8|
|Lieu, Christopher A; Chinta, Shankar J; Rane, Anand et al. (2013) Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's disease. PLoS One 8:e54200|
Showing the most recent 10 out of 77 publications